Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural platelet-rich plasma vs epidural steroid for herpes zoster neuralgia
ChiCTR2100053300Phase 4Recruiting
- Sponsor
- The University of Hong Kong-Shenzhen Hospital
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised trial of autologous platelet-rich plasma and betamethasone in postherpetic neuralgia (PHN) (2 arms), sponsored by The University of Hong Kong-Shenzhen Hospital. Primary endpoints: Pain score at 6 months and Percentage of pain relief at 6 months. Started Nov 2021; status: recruiting.
02
Drugs
autologous platelet-rich plasmabetamethasone
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2100053300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053300.